Oligodendroglioma Disease - Global Clinical Trials Review, H1, 2021
- $ 2500
- April 2024
- 251 pages
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Bladder Cancer, Brain Cancer, Breast Cancer, Carcinomas, Colorectal Cancer, Endometrial Cancer, Epithelial Ovarian Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Tract Cancer, Germ Cell Tumors, Glioblastoma Multiforme (GBM), Glioma, Hepatic - Colorectal Metastasis, Hepatocellular Carcinoma, Kidney Cancer (Renal Cell Cancer), Leiomyosarcoma, Lung Cancer, Melanoma, Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, Metastatic Prostate Cancer, Oligodendroglioma, Ovarian Cancer, Prostate Cancer, Rectal Cancer, Renal Cell Carcinoma, Sarcomas, Skin Cancer, Solid Tumor, Uterine Cancer